My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2021/1449 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (Text with EEA relevance)

Commission Implementing Regulation (EU) 2021/1449 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (Text with EEA relevance)

Implementing Regulation (EU) 2021/1449 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 18, 8-hydroxyquinoline, the date is replaced by ‘31 December 2022’; (2) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2022’; (3) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2022’; (4) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2022’; (5) in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2022’; (6) in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2022’; (7) in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2022’; (8) in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2022’; (9) in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2022’; (10) in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2022’; (11) in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2022’; (12) in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2022’; (13) in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2022’; (14) in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2022’; (15) in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2022’; (16) in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2022’; (17) in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2022’; (18) in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2022’; (19) in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2022’; (20) in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2022’; (21) in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2022’; (22) in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2022’; (23) in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2022’; (24) in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2022’; (25) in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2022’; (26) in the sixth column, expiration of approval, of row 276, Chlormequat, the date is replaced by ‘30 November 2022’; (27) in the sixth column, expiration of approval, of row 278, Propaquizafop, the date is replaced by ‘30 November 2022’; (28) in the sixth column, expiration of approval, of row 279, Quizalofop-P-ethyl and Quizalofop-P-tefuryl, the date is replaced by ‘30 November 2022’; (29) in the sixth column, expiration of approval, of row 284, Dimethachlor, the date is replaced by ‘31 December 2022’; (30) in the sixth column, expiration of approval, of row 285, Etofenprox, the date is replaced by ‘31 December 2022’; (31) in the sixth column, expiration of approval, of row 287, Penconazole, the date is replaced by ‘31 December 2022’; (32) in the sixth column, expiration of approval, of row 288, Tri-allate, the date is replaced by ‘31 December 2022’; (33) in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2022’; (34) in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 December 2022’; (35) in the sixth column, expiration of approval, of row 293, Tetraconazole, the date is replaced by ‘31 December 2022’; (36) in the sixth column, expiration of approval, of row 294, Paraffin oils, the date is replaced by ‘31 December 2022’; (37) in the sixth column, expiration of approval, of row 295, Paraffin oil, the date is replaced by ‘31 December 2022’; (38) in the sixth column, expiration of approval, of row 299, 2-phenylphenol (including its salts such as the sodium salt), the date is replaced by ‘31 December 2022’.

Other acts of the same type
Commission Delegated Regulation (EU) 2016/128 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for food for special medical purposes (Text with EEA relevance)Commission Regulation (EU) 2015/1608 of 24 September 2015 amending Annex IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for capric acid, paraffin oil (CAS 64742-46-7), paraffin oil (CAS 72623-86-0), paraffin oil (CAS 8042-47-5), paraffin oil (CAS 97862-82-3), lime sulphur and urea in or on certain products (Text with EEA relevance)Commission Implementing Regulation (EU) 2015/1609 of 24 September 2015 approving propiconazole as an existing active substance for use in biocidal products for product-type 7 (Text with EEA relevance)Commission Implementing Regulation (EU) 2015/1610 of 24 September 2015 approving Pythium oligandrum strain M1 as an active substance for use in biocidal products for product-type 10 (Text with EEA relevance)Commission Implementing Regulation (EU) 2015/1597 of 23 September 2015 derogating from Implementing Regulation (EU) No 615/2014 as regards the final date for the payment of the initial instalment of the advance to be paid to the beneficiary organisations in Greece in respect of work programmes in the olive oil and table olives sector for the year 2015Commission Implementing Regulation (EU) 2015/1606 of 23 September 2015 amending Regulation (EC) No 1484/95 as regards fixing representative prices in the poultrymeat and egg sectors and for egg albuminCommission Implementing Regulation (EU) 2015/1716 of 23 September 2015 approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (Olive de Nice (PDO))Commission Implementing Regulation (EU) 2015/1717 of 23 September 2015 approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (Noix du Périgord (PDO))Commission Implementing Regulation (EU) 2015/1724 of 23 September 2015 entering a name in the register of protected designations of origin and protected geographical indications [Silter (PDO)]Commission Implementing Regulation (EU) 2015/1721 of 22 September 2015 concerning the classification of certain goods in the Combined NomenclatureCommission Implementing Regulation (EU) 2015/1722 of 22 September 2015 concerning the classification of certain goods in the Combined NomenclatureCommission Implementing Regulation (EU) 2015/1723 of 22 September 2015 concerning the classification of certain goods in the Combined Nomenclature

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next